Greg Carlin and Kim Davis Publish
August 14, 2011
The article discusses a recent case heard by the United States Court of Appeals for the Federal Circuit (CAFC), Cancer Research Technology, Ltd. v. Barr Laboratories (CRT v. Barr). Carlin and Davis summarize the current state of the law on prosecution laches in view of CRT v. Barr and provide guidelines for practitioners needing to balance client needs with equitable obligations of timely prosecution.
The article appears in Volume 18, Issue 2 of Georgia State University’s Journal of Intellectual Property Law. View
Meunier Carlin & Curfman’s 2023 Georgia Super Lawyers and Rising Stars
Thomson Reuters’ Super Lawyers has named four litigators from Meunier Carlin & Curfman LLC as a Georgia Super Lawyer or...
Paul Tanpitukpongse Elected to MCC’s Partnership
Meunier Carlin & Curfman LLC (“MCC”) announces the promotion of Paul Tanpitukpongse to its partnership effective January 1, 2023. “Paul’s...
Meunier Carlin & Curfman Recognized as a Top Firm in Best Law Firms
Intellectual Property firm Meunier Carlin & Curfman LLC (“MCC”) earned several recognitions in the latest U.S. News – Best Lawyers...